Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV000488325 | SCV000574890 | likely benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | EFEMP2: BP4, BS1 |
Invitae | RCV000535424 | SCV000652054 | benign | Cutis laxa, autosomal recessive, type 1B | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000488325 | SCV000699428 | benign | not provided | 2017-07-14 | criteria provided, single submitter | clinical testing | Variant summary: The EFEMP2 c.277G>A (p.Gly93Ser) variant involves the alteration of a non-conserved nucleotide. 2/3 in silico tools predict a benign outcome for this variant (SNPsandGO not captured due to low reliability index). This variant was found in 354/122264 control chromosomes including ExAC, predominantly observed in the European (Finnish) subpopulation at a frequency of 0.009828 (65/6614). This frequency is about 88 times the estimated maximal expected allele frequency of a pathogenic EFEMP2 variant (0.0001118), suggesting this is likely a benign polymorphism found primarily in the populations of European (Finnish) origin. This variant has been found in multiple familial abdominal aortic aneurysm without evidence of segregation (van de Luijtgaarden_2015) and was classified as likely benign by the authors. One diagnostic laboratory has classified uncertain significance without evidence to independently evaluate. Taken together, this variant is classified as benign. |
Gene |
RCV000488325 | SCV000718335 | benign | not provided | 2018-11-30 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 26017485) |
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000535424 | SCV000744896 | likely benign | Cutis laxa, autosomal recessive, type 1B | 2017-05-31 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000535424 | SCV001156848 | benign | Cutis laxa, autosomal recessive, type 1B | 2023-11-29 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000535424 | SCV001266217 | benign | Cutis laxa, autosomal recessive, type 1B | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. |
Ambry Genetics | RCV002438189 | SCV002751675 | benign | Cardiovascular phenotype | 2019-01-29 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
CHEO Genetics Diagnostic Laboratory, |
RCV003485591 | SCV004240551 | benign | Familial thoracic aortic aneurysm and aortic dissection | 2023-05-16 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000535424 | SCV000745739 | likely benign | Cutis laxa, autosomal recessive, type 1B | 2014-02-04 | no assertion criteria provided | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000616268 | SCV001927397 | benign | not specified | no assertion criteria provided | clinical testing |